From February 2, 2024 to March 31, 2024, the company has repurchased 11,668,812 shares, representing 0.84% for CNY 84.62 million. With this, the company has completed the repurchase of 11,668,812 shares, representing 0.84% for CNY 84.62 million under the buyback announced on February 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.45 CNY | -4.91% | -6.32% | -45.13% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-45.13% | 845M | |
+41.06% | 6.19B | |
-15.95% | 4.48B | |
+6.36% | 3.29B | |
-11.34% | 3.12B | |
-3.12% | 2.5B | |
+45.41% | 1.94B | |
-7.74% | 1.68B | |
-0.67% | 1.64B | |
-11.32% | 1.56B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 3, 2024.